NCT02510937 - Safety and PK Study of CC-90001 in Subjects With Pulmonary Fibrosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 5, 2015

Primary Completion Date

February 6, 2017

Study Completion Date

February 6, 2017

Conditions

Pulmonary Fibrosis

Interventions

DRUG

CC-90001

Trial Locations (6)

St. Vincent's Hospital- Sydney, Darlinghurst

The Prince Charles Hospital, Chermside

University of Pittsburgh, Pittsburgh

Tampa General Hospital, Tampa

Vanderbilt University Medical Center, Nashville

LaPorte County Institute for Clinical Research, Inc, Michigan City